optimal use of medication: the quest for real-world evidence: julie frappier (data 4 actions)

14
Op#mal Use of Medica#on: the Quest for RealWorld Evidence The TOWWERS ini#a#ve Presented by Julie Frappier, Health Economist, Data 4 Ac<ons November 8th 2016 Canadian Expert Pa<ents in Health Technology

Upload: canadian-organization-for-rare-disorders

Post on 15-Apr-2017

127 views

Category:

Healthcare


2 download

TRANSCRIPT

Page 1: Optimal Use of Medication: the quest for real-world evidence: Julie Frappier (Data 4 Actions)

Op#mal  Use  of  Medica#on:  the  Quest  for  Real-­‐World  Evidence  

The  TOWWERS  ini#a#ve  Presented  by  Julie  Frappier,  Health  Economist,    Data  4  Ac<ons  November  8th  2016  Canadian  Expert  Pa<ents  in  Health  Technology    

Page 2: Optimal Use of Medication: the quest for real-world evidence: Julie Frappier (Data 4 Actions)

Healthcare  problema#c

Page 3: Optimal Use of Medication: the quest for real-world evidence: Julie Frappier (Data 4 Actions)

Significant  challenges

• Propor<on  of  HC  budget  and  increase  • AHA  

•  Lifestyle  change  •  Adherence  

• Chronic  disorders  • Silo’s:  performance  indicators  • Mul<disciplinary  team  

• Who  is  the  real  pa<ent  manager?  •  Imputbaility  –  5Ps  • RWE  

• HTA  

Page 4: Optimal Use of Medication: the quest for real-world evidence: Julie Frappier (Data 4 Actions)
Page 5: Optimal Use of Medication: the quest for real-world evidence: Julie Frappier (Data 4 Actions)

Wastage  

Disease  Progression    or    Complica3ons  

Therapeu3c  target  

Why  treat?  Why  pay?  

Page 6: Optimal Use of Medication: the quest for real-world evidence: Julie Frappier (Data 4 Actions)

Clear  message…  Or  else...

Page 7: Optimal Use of Medication: the quest for real-world evidence: Julie Frappier (Data 4 Actions)

Example  -­‐  Asthma

    Efficacy   Good  use  –  mechanism   RWE  

Inhaler  

Pill  

       

90%  

80%  

Δ  10%  

30%  

90%  

27%  

72%  

 Δ  45%  

“The goal is to turn data into information, and information into insight.” … data for/4 actionable powerful strategies* Carly Fiorina, Former executive, president, and chair of Hewlett-Packard Co. *Julie Frappier, Health Economist, Data 4 Actions, Creator of TOWWERS program.

 

Page 8: Optimal Use of Medication: the quest for real-world evidence: Julie Frappier (Data 4 Actions)

Powered  by  

Page 9: Optimal Use of Medication: the quest for real-world evidence: Julie Frappier (Data 4 Actions)

2  in  1 PHR  that  feeds  a  Clinical  Registry  of  RWE

*        PHR:  Pa<ent  health  record  **  RWE:  Real-­‐World  Evidence  

Page 10: Optimal Use of Medication: the quest for real-world evidence: Julie Frappier (Data 4 Actions)

Informa#on  électronique  -­‐  pa#ent

•  «  La  réalité  est  que  le  dysfonc<onnement  et  l’inefficacité  sont  intégrés  dans  nos  systèmes,  es<me  la  ministre  Philpoa.  C’est  choquant  à  l’ère  de  Facebook  et  du  commerce  électronique,  la  plupart  des  Canadiens  ne  peuvent  pas  consulter  leur  dossier  médical  en  ligne  »,  dit-­‐elle,  voulant  aussi  que  la  prise  de  rendez-­‐vous  et  certaines  consulta<ons  médicales  puissent  se  faire  en  ligne.  

Édi<on  du  17  octobre  2016,  La  Presse+  

•  Les  plans  de  traitement  partagés  auprès  des  pa<ents    •  Le  pa<ent  prend  les  notes  lui-­‐même  •  L’infirmière  peut  «  écrire  »  sur  un  bout  de  pa<ent  

•  Cependant  les  objec<fs  mesurables  sont  inscrits  dans  son  dossier  pa<ent  

Manon,  infirmière  dans  un  GMF  

Page 11: Optimal Use of Medication: the quest for real-world evidence: Julie Frappier (Data 4 Actions)

1)  Op<mal  use  of  medica<on:  reaching  a  clinical  marker  

Partage  d’informa3on  de  façon  systéma3que  

ýPlan  d’ac<on!  þOrdonnance  ýDiagnos<c!  ýCibles  Thérapeu<ques!  

Informa<on  individuelle  Saisie  de  données  homogène  

DSQ  +  PODC  

Page 12: Optimal Use of Medication: the quest for real-world evidence: Julie Frappier (Data 4 Actions)

2)  RWE  Registry  │  5P  

Base  de  données  DIXIE  

1)  Real-­‐World  Evidence    TPP  

Regulatory  agences*  Risk-­‐Sharing  

2)  Care  Gap:    expenditure  vs  investment  

3)  Off  label  and  encouraging  research    

4)  Innova<on  

5)  …    

               Data  4  Ac3ons  Ac3ons  4  Data  

Page 13: Optimal Use of Medication: the quest for real-world evidence: Julie Frappier (Data 4 Actions)

 

 

 

 

Together  for  tomorrow’s  health Together  for  tomorrow’s  wealth  

 

Establishment  of  measurable  criteria    

Ongoing  measurement-­‐  PODC  (Résultats  cliniques,  mécanismes  &  efficience)  

Collabora3on  and  overcoming  silos  Care  Gap  analysis  and  Recommenda3ons  

Page 14: Optimal Use of Medication: the quest for real-world evidence: Julie Frappier (Data 4 Actions)

Thank  you! Together  for  tomorrow’s  health

Together  for  tomorrow’s  wealth